Weekly Recap | Mercadolibre -1.95%, most brokers rate it buy
I'm LongbridgeAI, I can summarize articles.Mercadolibre (MELI) fell 1.95% this week to close at $1,752.61, while the S&P 500 gained 1.21%, leaving the stock about 3.16 percentage points behind the benchmark. The path was a fade after an early push: Monday opened near $1,790.50 and briefly reached $1,842.49, with Tuesday still holding around $1,826; selling picked up from Wednesday, Thursday traded down to $1,736.85, and Friday bottomed at $1,715.35 before a small recovery into the close. The week’s range was 7.
The Week
Mercadolibre (MELI) fell 1.95% this week to close at $1,752.61, while the S&P 500 gained 1.21%, leaving the stock about 3.16 percentage points behind the benchmark. The path was a fade after an early push: Monday opened near $1,790.50 and briefly reached $1,842.49, with Tuesday still holding around $1,826; selling picked up from Wednesday, Thursday traded down to $1,736.85, and Friday bottomed at $1,715.35 before a small recovery into the close. The week’s range was 7.1%, with average daily volume of 826,630 shares, roughly double the median over the prior 60 sessions, so the pullback came on heavier turnover.
Key Events
The most direct company news this week was about Brazil. On 25 September, reports said MercadoLibre is set to launch one-hour delivery and expand its pharmacy business in Brazil, extending its local fulfilment and high-frequency category push. Most other items were peripheral: early in the week a piece revisited the return on a $1,000 investment in MercadoLibre a decade ago; New Street Research started coverage with a buy rating on Wednesday; Friday brought a whale-alert scan of consumer discretionary names and a broader article on US retail share ownership. There was no company earnings release or major regulatory filing this week, so the main thread was Brazilian fulfilment expansion.
Analyst Ratings
As of 25 September 2026, 25 firms cover the stock: 16 rate it buy, 4 overweight and 5 hold, with no underweight or sell ratings. The consensus rating is buy, with a consensus target of $2,272.28, about 29.65% above the current price. Targets range widely from $1,750 to $2,800. Within its industry the stock ranks 8th out of 25, while the industry mean is 18 and the median 14, so coverage is relatively deep.
The Week Ahead
The macro calendar is US-heavy: Dallas Fed manufacturing activity on Monday, then FHFA house prices, Case Shiller home prices, JOLTS job openings and consumer confidence on Tuesday. These do not sit in the same frame as LatAm assets, but they feed through to the dollar and risk appetite for high-multiple US growth stocks. On the company side there is no earnings date nearby; the more relevant watch items are follow-through on the Brazil one-hour delivery news and whether the stock can stabilise after this week’s heavy-volume pullback.
In Short
The signals are mixed this week: the stock fell on above-average volume and lagged the market, yet the consensus rating remains buy with a target nearly 30% above spot; valuation is also not cheap at roughly 47.7x P/E and 11.34x P/B. In the latest session’s money flow, large-lot orders were net sellers while medium and small orders were net buyers, pointing to split positioning. The open question is whether Brazilian fulfilment expansion can feed new revenue expectations, and whether this high-valuation, divided-flow mix holds up as next week’s macro data rolls in.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
